Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Research and Development Expenses (Details) - Schedule of research and development expenses

v3.22.1
Research and Development Expenses (Details) - Schedule of research and development expenses - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Schedule of research and development expenses [Abstract]    
Payroll and related benefits (including share-based compensation) $ 3,748 $ 2,273
Raw materials subcontracted work and consulting 1,440 1,058
Others 689 478
Total $ 5,877 $ 3,809